Lemaitre Vascular LMAT
NASDAQ LMAT
$78.96 -1.23 (-1.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lemaitre Vascular (LMAT) Gains from Sales and Divestitures (2013 - 2023)

Updated

Lemaitre Vascular's Gains from Sales and Divestitures came in at -$485,000 for FY2023, compared with -$1.95 million in FY2022.

Analysis

Lemaitre Vascular (LMAT) Gains from Sales and Divestitures (2013 - 2023) Analysis & Trends

Going back to FY2009, Lemaitre Vascular's Gains from Sales and Divestitures data covers 11 years.

  • The FY2023 figure represents the highest annual Gains from Sales and Divestitures since FY2020.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$1.95 million in FY2022 and $470,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Lemaitre Vascular 1.81 Bn 359.77 Mn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -180,000.00
Mar 31, 2023 -305,000.00
Dec 31, 2022 -548,000.00
Sep 30, 2022 548,000.00
Jun 30, 2022 -1.95 Mn
Sep 30, 2020 470,000.00
Dec 31, 2018 1.60 Mn
Jun 30, 2018 5.88 Mn
Sep 30, 2015 360,000.00
Dec 31, 2014 -4,000.00
Mar 31, 2014 -4,000.00
Dec 31, 2013 -15,000.00
API Access

Lemaitre Vascular Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LMAT&period=max&api_key=YOUR_API_KEY